Specifically, the median expression of CBX2 showed an evident increase with more advanced tumor stages in pRCC, while the median expression of CBX7 showed decreasing trends in both RCC subtypes (Figure 3). This evidence concerns the gene CBX7 and renal cell carcinoma.